Skip to content
Recall Observatory FDA recall evidence

Drug product

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, NDC 72606-558-01.

D-0123-2021

December 08, 2020

Class II

Product summary

Firm
Shilpa Medicare Limited
Event
Event 86749
Status
Terminated
Classification
Class II
Quantity
6,560 vials
Official record key
drug-enforcement:D-0123-2021

Official wording

Reason: CGMP Deviations

Code information: Lot #: 7S10227A, Exp. 10/31/2021

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations